Johnson & Johnson (NYSE:JNJ) dropped slightly amid mild profit booking and the last known price was $116.99 per share. The price decreased by -0.02 points or -0.02% which made the investors to buy on weakness. For the latest trading session, the net money flow was recorded at $19.35 million. The total upticks were valued at $111.89 million and the total downticks aggregated to $92.54 million, thereby putting the up/down ratio at 1.21,. The shares have seen a change in the share price of 1.94% on a weekly basis.In a big block trade which occurred today, the total uptick value was $20.58 million and the total downtick value was $3.51, resulting in an up/down ratio of 5.86. The net money flow for the block trade was calculated to be $17.07 million.
Currently the company Insiders own 0.11% of Johnson & Johnson shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -18.24% . Institutional Investors own 67.95% of Johnson & Johnson shares. During last six month period, the net percent change held by insiders has seen a change of -18.24%. On the companys insider trading activities, The officer (Exec VP, WW Chair, Med Devices), of Johnson & Johnson, Pruden Gary J had unloaded 9,735 shares at $116.03 per share in a transaction on June 7, 2016. The total value of transaction was $1,129,552. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Johnson & Johnson (NYSE:JNJ) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.22 points or 0.19% at $116.79 with 7,940,893 shares getting traded. Post opening the session at $117.13, the shares hit an intraday low of $116.79 and an intraday high of $117.64 and the price was in this range throughout the day. The company has a market cap of $321,248 million and the number of outstanding shares have been calculated to be 2,750,644,300 shares. The 52-week high of Johnson & Johnson (NYSE:JNJ) is $117.64 and the 52-week low is $81.79.
Many analysts have stated their opinion on the company shares. Standpoint Research initiates coverage on Johnson & Johnson (NYSE:JNJ) The current rating of the shares is Sell. The rating by the firm was issued on May 20, 2016.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.